| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CRMD sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 774.7K | - | - | |
| COO | 270.5K | $2.24M | - | |
| Other | 260.7K | $2.16M | - | |
| Dir | 201.0K | $2.22M | - | |
| Other | 133.2K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 30, 2025 | Dunton Alan W86 | Director | Sale+OE | 20,000 | $13.00 | $260,000.00 | -33.2% | -47.4% | - | |
| Dec 18, 2025 | Todisco Joseph76 | Chief Executive Officer | Sale+OE | 30,000 | $12.00 | $360,000.00 | -5.6% | -46.6% | - | |
| Dec 9, 2025 | Lefkowitz Steven W | Director | Sell | 40,000 | $11.88 | $475,200.00 | -33.2% | -43.5% | - | |
| Dec 9, 2025 | Dillione Janet63 | Director | Sale+OE | 34,000 | $12.00 | $408,000.00 | -41.2% | -43.5% | - | |
| Dec 2, 2025 | Dillione Janet63 | Director | Sale+OE | 46,657 | $10.00 | $466,570.00 | -49.0% | -26.2% | - | |
| Nov 24, 2025 | Dillione Janet63 | Director | Sale+OE | 26,343 | $9.93 | $261,585.99 | -35.2% | -28.7% | - | |
| Nov 14, 2025 | Dillione Janet63 | Director | Sell | 30,000 | $11.42 | $342,600.00 | -38.2% | -34.5% | - | |
| Oct 23, 2025 | Kaplan Myron | Director | Buy | 25,000 | $11.02 | $275,500.00 | +14.2% | -35.2% | - | |
| Sep 12, 2025 | Todisco Joseph76 | Chief Executive Officer | Sale+OE | 50,000 | $13.00 | $650,000.00 | -8.9% | -9.3% | - | |
| Sep 12, 2025 | Dunton Alan W86 | Director | Sale+OE | 10,000 | $13.13 | $131,300.00 | -19.9% | -9.3% | - |